| Line Item | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating expense: | ||||||||||||||||
| Research and Development Expense | ||||||||||||||||
| Depreciation Expense | ||||||||||||||||
| Selling, General and Administrative Expense | ||||||||||||||||
| Total operating expense | ||||||||||||||||
| Other income (loss) | ||||||||||||||||
| Interest Income | ||||||||||||||||
| Loss on derivative instruments | — | — | ||||||||||||||
| Realized and unrealized gain on marketable equity securities | — | — | ||||||||||||||
| Total other income (loss) | ||||||||||||||||
| Net loss | ||||||||||||||||
| Earnings Per Share (Diluted) | — |